1)神経変性疾患のトランスレーショナルリサーチ

Saved in:
Bibliographic Details
Published in日本内科学会雑誌 Vol. 101; no. 9; pp. 2533 - 2538
Main Authors 祖父江, 元, 田中, 章景, 坂野, 晴彦, 鈴木, 啓介, 勝野, 雅央, 足立, 弘明, 橋詰, 淳
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本内科学会 2012
Subjects
Online AccessGet full text
ISSN0021-5384
1883-2083
DOI10.2169/naika.101.2533

Cover

Author 田中, 章景
勝野, 雅央
橋詰, 淳
足立, 弘明
坂野, 晴彦
祖父江, 元
鈴木, 啓介
Author_xml – sequence: 1
  fullname: 祖父江, 元
  organization: 名古屋大学大学院医学系研究科神経内科
– sequence: 1
  fullname: 田中, 章景
  organization: 名古屋大学大学院医学系研究科神経内科
– sequence: 1
  fullname: 坂野, 晴彦
  organization: 名古屋大学高等研究院
– sequence: 1
  fullname: 鈴木, 啓介
  organization: 名古屋大学大学院医学系研究科神経内科
– sequence: 1
  fullname: 勝野, 雅央
  organization: 名古屋大学大学院医学系研究科神経内科
– sequence: 1
  fullname: 足立, 弘明
  organization: 名古屋大学大学院医学系研究科神経内科
– sequence: 1
  fullname: 橋詰, 淳
  organization: 名古屋大学大学院医学系研究科神経内科
BookMark eNo9kDtLA0EUhQeJYIxp_Rcb587sTHZKDb4gYKP1cvelG2OU3TR2ZqcxwdrSRiX4wEaCCME_czEp_QuaKDbnwPngFN8yK3VOOzFjq8BrArRZ62B6jDXgUBNKygVWBs-TjuCeLLEy5wIcJT13iVXzPA24K7XyQLpl1oCvcX96fzMdXX3e9ScXw-n1x6S4pd4L2UuyD2RfqXgn-0x2TMUb2SHZAdknso9UjGaj7a2wxQTbeVz96wo72Nrcb-w4zb3t3cZ602mB5tzRYFQShgmoABFFXSfGKEQvAEwkxFEAoDggD8MgCcDVQrlaRUaDkGjqJpIVtvH728q7eBj7Z1l6gtm5j1k3DduxP3fg_zjwzTxnJv5heISZ30L5DXQ1cA4
ContentType Journal Article
Copyright 2012 一般社団法人 日本内科学会
Copyright_xml – notice: 2012 一般社団法人 日本内科学会
DOI 10.2169/naika.101.2533
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1883-2083
EndPage 2538
ExternalDocumentID article_naika_101_9_101_2533_article_char_ja
GroupedDBID 2WC
ALMA_UNASSIGNED_HOLDINGS
DIK
F5P
JSF
OK1
RJT
ZXP
ID FETCH-LOGICAL-j1600-6195fccf15baaa276f995aa8b1af31edb11501a0ccbfb14625465d96123a979d3
ISSN 0021-5384
IngestDate Wed Sep 03 06:30:35 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 9
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j1600-6195fccf15baaa276f995aa8b1af31edb11501a0ccbfb14625465d96123a979d3
OpenAccessLink https://www.jstage.jst.go.jp/article/naika/101/9/101_2533/_article/-char/ja
PageCount 6
ParticipantIDs jstage_primary_article_naika_101_9_101_2533_article_char_ja
PublicationCentury 2000
PublicationDate 2012
PublicationDateYYYYMMDD 2012-01-01
PublicationDate_xml – year: 2012
  text: 2012
PublicationDecade 2010
PublicationTitle 日本内科学会雑誌
PublicationTitleAlternate 日内会誌
PublicationYear 2012
Publisher 一般社団法人 日本内科学会
Publisher_xml – name: 一般社団法人 日本内科学会
References 2) Rosen DR, et al: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62, 1993.
12) Cudkowicz ME, et al: Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11: 259-265, 2010.
11) Goedert M, et al: The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33: 317-325, 2010.
1) Goate A, et al: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-706, 1991.
6) Shulman JM, et al: Pakinson's disease: genetics and pathogenesis. Annu Rev Pathol 6: 193-222, 2011.
9) Cohen TJ, et al: TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med 17: 659-667, 2011.
7) Katsuno M, et al; Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group: Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 9: 875-884, 2010.
4) Zinman L, Cudkowicz M: Emerging targets and treatments in amyotrophic lateral sclerosis. Lancet Neurol 10: 481-490, 2011.
3) Holmes C, et al: Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372: 216-223, 2008.
8) Hashizume A, et al: Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy. J Neurol 259: 712-719, 2011.
10) Boillée S, et al: Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389-1392, 2006.
5) Katsuno M, et al: Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases. J Neurol Neurosurg Psychiatry 83: 329-335, 2012.
References_xml – reference: 2) Rosen DR, et al: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62, 1993.
– reference: 7) Katsuno M, et al; Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group: Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 9: 875-884, 2010.
– reference: 1) Goate A, et al: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-706, 1991.
– reference: 10) Boillée S, et al: Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389-1392, 2006.
– reference: 9) Cohen TJ, et al: TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med 17: 659-667, 2011.
– reference: 4) Zinman L, Cudkowicz M: Emerging targets and treatments in amyotrophic lateral sclerosis. Lancet Neurol 10: 481-490, 2011.
– reference: 5) Katsuno M, et al: Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases. J Neurol Neurosurg Psychiatry 83: 329-335, 2012.
– reference: 3) Holmes C, et al: Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372: 216-223, 2008.
– reference: 11) Goedert M, et al: The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33: 317-325, 2010.
– reference: 6) Shulman JM, et al: Pakinson's disease: genetics and pathogenesis. Annu Rev Pathol 6: 193-222, 2011.
– reference: 12) Cudkowicz ME, et al: Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11: 259-265, 2010.
– reference: 8) Hashizume A, et al: Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy. J Neurol 259: 712-719, 2011.
SSID ssib043658134
ssj0066765
ssib002821954
ssib005879745
ssib007485360
ssib058493862
ssib000940260
ssib002484664
Score 1.8811975
SourceID jstage
SourceType Publisher
StartPage 2533
SubjectTerms エンドポイント
トランスレーショナルリサーチ
バイオマーカー
神経変性疾患
臨床試験
Title 1)神経変性疾患のトランスレーショナルリサーチ
URI https://www.jstage.jst.go.jp/article/naika/101/9/101_2533/_article/-char/ja
Volume 101
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本内科学会雑誌, 2012, Vol.101(9), pp.2533-2538
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1NaxQxdKgVxIv4id_0YE4ydZOZTBI8ZaazFKWC0EJvy3we9lBFthdPdudixbNHLyrFD7xIEaH4Zwa7R2-efS8z2Z2FHmyFYXibvLy8j83mvWzy4jh30pLlLClKF7w33_VZKl1ZwHBXXLKUwa-yZ_4uWHsUrG74Dzb55sKpP51dS9ujdDl7fuS5kpNYFcrArnhK9hiWnRKFAoDBvvAGC8P7n2xMSdwnYUSkIrEgmhMVIxByIiMSc6J9UxXgdgYtsEoFJIxNCSPaI7EHniTRsQHgkS2gVQuEDQ4joS3Rka2KbJWwVRaQ2paEFtAWmc83Rwa6DjLypowsCESmOxAHGOZGRhCBGtFWiA5I7CMdBcQVUaGpktiXnK79WsUECIB8YYCEQ0pUH79dhjg8XhdfAdWeoS2xH4MmUBbdM1wpovszfCC-gpIBCxK6iBt8gxb6WB0iqzN8ZdjwrXzSsqHg8UyvIZFhdzWGzqL2liuwJwgKdFA9Au2MVuWoA7RqgHYDeois4bl7Mq12ZzRGXZi0mkWZopnEpPRgnLSqs7Ncu2bUDGfVnbN4k4qk9X_gozxqbmU0wNS0W3iyDdd8lmft5vKVt6NhYBBxB-FAmTeiD2wlHikcDCGuOc2EoLgV9-HjTligfEx113Ej5dwtCEwy2k1jyKVQ3VsbhA9O6Ky974GbTWdpEMHnVp4MpmnmcJt3c9NJq8smuSsKfG9eXHBThxC02Q2fxgddP--ca4PHJd2Id8FZGCYXnTNr7faYS05Efx_sTj68ney__vV-9_DF3uTNz8Pxu3rna129rKuPdfWtHv-oqy91dVCPv9fVXl29qqvPdfWpHu9jYbVz2dnox-vRqtvekuIOKUQrbgCqKLOspDxNkoSJoFSKJ4lMaVJ6tMhTjPlo0suytEzBL8ILMHiuMO1SooTKvSvO4taTreKqs1SWKs9EwQsvE36RpIrnrIdH1XPQrs-Ka879RvzB0yYVzuA4xr7-X61vOGdxvDWrnzedxdGz7eIWxAOj9Lb58vwFZzLP8w
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=1%EF%BC%89%E7%A5%9E%E7%B5%8C%E5%A4%89%E6%80%A7%E7%96%BE%E6%82%A3%E3%81%AE%E3%83%88%E3%83%A9%E3%83%B3%E3%82%B9%E3%83%AC%E3%83%BC%E3%82%B7%E3%83%A7%E3%83%8A%E3%83%AB%E3%83%AA%E3%82%B5%E3%83%BC%E3%83%81&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E7%A5%96%E7%88%B6%E6%B1%9F%2C+%E5%85%83&rft.au=%E7%94%B0%E4%B8%AD%2C+%E7%AB%A0%E6%99%AF&rft.au=%E5%9D%82%E9%87%8E%2C+%E6%99%B4%E5%BD%A6&rft.au=%E9%88%B4%E6%9C%A8%2C+%E5%95%93%E4%BB%8B&rft.date=2012&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5384&rft.eissn=1883-2083&rft.volume=101&rft.issue=9&rft.spage=2533&rft.epage=2538&rft_id=info:doi/10.2169%2Fnaika.101.2533&rft.externalDocID=article_naika_101_9_101_2533_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5384&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5384&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5384&client=summon